BIOMAT Database Logo BIOMAT Database Logo

[The trials of determination of acute leukemia blasts sensitivity against cytostatics (author's transl)]. 1981

K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Therapeutic trials with cytostatics (author's transl)].
August 1977, Blut,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Testing of bronchial carcinoma for sensitivity against cytostatics in tissue culture (author's transl)].
January 1976, Archiv fur Geschwulstforschung,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[New cytostatics (author's transl)].
June 1978, Casopis lekaru ceskych,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Different maturation of leukemic blasts in tumor--like type of acute infantile leukemia (author's transl)].
January 1975, Padiatrie und Padologie,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Principles of clinical trials of new cytostatics in the CMEA counteries (author's transl)].
November 1976, Casopis lekaru ceskych,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Stability of clinically used cytostatics (author's transl)].
January 1975, Archiv fur Geschwulstforschung,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Effects of cytostatics on spermatogenesis (author's transl)].
January 1973, Andrologie,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Immunotherapy of acute leukemia (author's transl)].
September 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[New cytostatics: bleomycin and adriamycin (author's transl)].
September 1973, Therapeutische Umschau. Revue therapeutique,
K Grazybek-Hryncewicz, and I Biernacka, and W Brzuchowska, and K Kuliczkowski, and A Luczkiewicz-Mulczykowa, and S Kotlarek-Haus
[Septicemia in acute leukemia (author's transl)].
April 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!